- Home
- ZLAB vs PIPR Comparison
ZLAB vs PIPR Comparison
Compare ZLAB & PIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- PIPR
- Stock Information
- Founded
- ZLAB 2013
- PIPR 1895
- Country
- ZLAB China
- PIPR United States
- Employees
- ZLAB N/A
- PIPR N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- PIPR Investment Bankers/Brokers/Service
- Sector
- ZLAB Health Care
- PIPR Finance
- Exchange
- ZLAB Nasdaq
- PIPR Nasdaq
- Market Cap
- ZLAB 3.5B
- PIPR 4.0B
- IPO Year
- ZLAB 2017
- PIPR N/A
- Fundamental
- Price
- ZLAB $29.44
- PIPR $257.57
- Analyst Decision
- ZLAB Buy
- PIPR Hold
- Analyst Count
- ZLAB 4
- PIPR 3
- Target Price
- ZLAB $47.37
- PIPR $286.00
- AVG Volume (30 Days)
- ZLAB 1.4M
- PIPR 163.6K
- Earning Date
- ZLAB 05-08-2025
- PIPR 05-02-2025
- Dividend Yield
- ZLAB N/A
- PIPR 2.25%
- EPS Growth
- ZLAB N/A
- PIPR 93.72
- EPS
- ZLAB N/A
- PIPR 11.46
- Revenue
- ZLAB $398,988,000.00
- PIPR $1,540,130,000.00
- Revenue This Year
- ZLAB $44.43
- PIPR $14.95
- Revenue Next Year
- ZLAB $48.68
- PIPR $15.68
- P/E Ratio
- ZLAB N/A
- PIPR $21.67
- Revenue Growth
- ZLAB 49.59
- PIPR 10.55
- 52 Week Low
- ZLAB $15.65
- PIPR $201.97
- 52 Week High
- ZLAB $39.77
- PIPR $351.80
- Technical
- Relative Strength Index (RSI)
- ZLAB 38.00
- PIPR 60.19
- Support Level
- ZLAB $30.96
- PIPR $240.43
- Resistance Level
- ZLAB $32.02
- PIPR $259.93
- Average True Range (ATR)
- ZLAB 1.14
- PIPR 7.69
- MACD
- ZLAB -0.27
- PIPR 3.62
- Stochastic Oscillator
- ZLAB 4.87
- PIPR 91.16
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About PIPR Piper Sandler Companies
Piper Sandler Cos is an investment banking company. Investment banking services include financial advisory services, management of and participation in underwriting, and public finance activities. It generates maximum revenue from Advisory services followed by Equity financing. The company focuses on the following sectors: healthcare; energy; consumer; diversified industrials and services; business services; technology; financial services; agriculture, clean technologies, and renewables, focusing on middle-market clients.